The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate if minocycline limits the development of negative
symptoms in early psychosis and to test via what mechanism of action this change occurs.
Phase:
Phase 2
Details
Lead Sponsor:
University of Manchester
Collaborators:
Cambridgeshire and Peterborough NHS Foundation Trust Camden and Islington NHS Foundation Trust Central and North West London NHS Foundation Trust Greater Manchester Mental Health NHS Foundation Trust Greater Manchester West Mental Health NHS Foundation Trust King's College London Lancashire Care NHS Foundation Trust Manchester Mental Health & Social Care Trust NHS Borders NHS Fife NHS Lothian North East London Foundation Trust Salford Royal NHS Foundation Trust South London and Maudsley NHS Foundation Trust University College, London University Hospital Birmingham NHS Foundation Trust University of Birmingham University of Cambridge University of Edinburgh West London Mental Health NHS Trust